Bortenat 3.5mg (Bortezomib) Injection

Bortenat 3.5mg contains Bortezomib, a chemotherapy drug used to treat certain types of blood cancer. It works by blocking specific proteins in cancer cells, leading to their death.

✅ Primary Uses:

Multiple Myeloma

A type of blood cancer that affects plasma cells in the bone marrow.

Bortenat helps slow disease progression and reduce symptoms.

Mantle Cell Lymphoma (MCL)

A rare, aggressive form of non-Hodgkin lymphoma.

Bortenat is used when other treatments haven't worked or as a first-line treatment in some cases.

⚙️ How It Works:

Bortezomib inhibits proteasomes, which are cell structures that break down proteins.

Blocking this process causes a buildup of proteins in cancer cells, leading to cell stress and death—especially in fast-growing cancer cells.

💉 Administration:

Given by injection under the skin (subcutaneously) or directly into a vein (intravenously).

Administered in cycles under the guidance of a healthcare professional, often in a hospital or oncology clinic.

⚠️ Common Side Effects:

Fatigue or weakness

Nausea, vomiting, or diarrhea

Low blood cell counts (risk of infection, anemia)

Nerve pain or tingling (peripheral neuropathy)

Dizziness or low blood pressure

❗ Precautions:

Monitor blood counts and liver function regularly during treatment.

Not recommended during pregnancy or breastfeeding.

Inform your doctor about other medications or existing health conditions before starting.